EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research-Reference-Cited by-全球学者库

EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research

Published:2021-05 Issue: Volume:167 Page:105583
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Dong Rui-Fang,Zhu Miao-Lin,Liu Ming-Ming,Xu Yi-Ting,Yuan Liu-Liu,Bian Jing,Xia Yuan-Zheng,Kong Ling-Yi

Funder

Ministry of Education of the People's Republic of China

China Pharmaceutical University State Key Laboratory Of Natural Medicines

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference184 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: Cancer J. Clin.,2021

2. Cancer treatment and survivorship statistics,2019;Miller;CA Cancer J. Clin.,2019

3. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N. Engl. J. Med.,2009

4. Overview of current systemic management of EGFR-mutant NSCLC;Hsu;Ann. Oncol.,2018

5. Mechanisms of resistance to egfr tyrosine kinase inhibitors and therapeutic approaches: an update;Ahsan;Adv. Exp. Med. Biol.,2016

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel aminopyrimidine derivatives for the treatment of mutant NSCLC;European Journal of Medicinal Chemistry;2024-02

2. JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers;Cancer Letters;2024-02

3. Alginate microspheres encapsulating hox transcript antisense RNA siRNA regulate the Hedgehog-Gli1 pathway to alleviate epidermal growth factor receptor tyrosine kinase inhibitors resistance;Journal of Biomaterials Applications;2024-01-23

4. Targeting EGFR allosteric site with marine-natural products of Clathria Sp.: A computational approach;Current Research in Structural Biology;2024

5. Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma;Cell Communication and Signaling;2023-12-18